Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:administeredBy |
gptkb:DTaP_vaccine
gptkb:Tdap_vaccine |
| gptkbp:antigen |
inactivated bacterial proteins
|
| gptkbp:approvedBy |
gptkb:World_Health_Organization
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:component |
gptkb:Tdap
gptkb:DTaP |
| gptkbp:contains |
purified pertussis antigens
|
| gptkbp:introducedIn |
1990s
|
| gptkbp:prevention |
pertussis
|
| gptkbp:recommendation |
adolescents
adults children |
| gptkbp:replacedBy |
gptkb:whole-cell_pertussis_vaccine
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue injection site soreness |
| gptkbp:bfsParent |
gptkb:Bordetella_pertussis
gptkb:pertussis_toxin |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
acellular pertussis vaccine
|